Oxbridge Re Holdings Limited (NASDAQ:OXBR) Short Interest Down 63.2% in August

Oxbridge Re Holdings Limited (NASDAQ:OXBR) was the target of a significant decrease in short interest in August. As of August 31st, there was short interest totaling 41,747 shares, a decrease of 63.2% from the August 15th total of 113,543 shares. Based on an average trading volume of 9,235 shares, the short-interest ratio is presently 4.5 days. Currently, 0.6% of the shares of the company are short sold.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on OXBR. Maxim Group dropped their price objective on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research note on Tuesday, June 16th. Zacks Research lowered shares of Oxbridge Re from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 18th. Finally, Weiss Ratings raised shares of Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a report on Friday, August 14th. One analyst has rated the stock with a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Oxbridge Re presently has an average rating of “Reduce” and a consensus target price of $3.00.

Institutional Investors Weigh In On Oxbridge Re

A hedge fund recently bought a new stake in Oxbridge Re stock. Citadel Advisors LLC bought a new position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 65,855 shares of the insurance provider’s stock, valued at approximately $68,000. Citadel Advisors LLC owned about 0.81% of Oxbridge Re as of its most recent SEC filing. Institutional investors and hedge funds own 5.64% of the company’s stock.

Oxbridge Re Stock Down 5.1%

Shares of NASDAQ:OXBR traded down $0.08 during midday trading on Monday, hitting $1.49. The stock had a trading volume of 12,731 shares, compared to its average volume of 17,249. The company’s 50-day moving average price is $1.42 and its 200-day moving average price is $1.11. Oxbridge Re has a fifty-two week low of $0.66 and a fifty-two week high of $2.86. The company has a market capitalization of $12.13 million, a P/E ratio of 74.54 and a beta of 1.97.

Oxbridge Re (NASDAQ:OXBR) last posted its quarterly earnings results on Thursday, August 13th. The insurance provider reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%.The business had revenue of $0.94 million for the quarter, compared to analyst estimates of $1.10 million. Research analysts expect that Oxbridge Re will post -0.08 EPS for the current fiscal year.

Oxbridge Re Company Profile

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.